Vitrolife's Press Release of Annual Accounts 2003

2004-02-18 - 12:07

Vitrolife's Press Release of Annual Accounts 2003 Increase in sales with profit and positive cash flow · Total net sales were SEK 96,3 million (103,3 - net sales of SEK 28,1 million is from assigned companies) · Core business net sales increased by 28 per cent, in spite of negative currency influence, and amounted to SEK 96,3 million (75,2) · Gross profit totalled SEK 61,6 million (49,4) and in per cent of turnover of 64 per cent (48) · The group´s net result totalled SEK 44,7 million whereof SEK 42,3 million is an item affecting comparability regarding mainly the sales of Alife (-116,5 whereof items affecting comparability -89,4) · Operating result for quarter four amounted to SEK 3,0 million (-110,2 whereof -87,6 is items affecting comparability) · Result per share SEK 2,4 (-6,3) · Vitrolife divested in August its subsidiary which developed products for aestctic facial surgery based on cross-linked Hyaluronic acid to Mentor Corp., USA for SEK 60 million free of debt plus royalty on future sales · Vitrolife received market clearance from FDA to marketing EmbryoGlue® For further information, please contact: CEO: Magnus Nilsson Tel: +46 31 721 80 00 Mobile +46 708 22 80 61 CFO and IR agent: Anders Sävfält Tel: +46 31 721 80 00 Mobile: +46 708 22 80 13 Vitrolife is a global biomedical corporation that works with products for cell and tissue technology. The Vitrolife group consists of the parent company, Vitrolife AB (Publ) and two wholly owned subsidiaries: Vitrolife Sweden AB (Gothenburg, Sweden), Vitrolife Inc. (Denver, Colorado). The group's operations focused on three geographic areas. · Europe/Middle East · The Americas · Rest of the World Vitrolife's business concept is to develop, produce and sell advanced products and systems for the preparation, cultivation, preservation and support of cells, tissues and organs. ------------------------------------------------------------ This information was brought to you by Waymaker The following files are available for download: The full year end report